Doses of pharmaceutical grade acetyldigitoxin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Liver Organs at Risk Kidney Brain Lung Cell Line, Tumor

Organisms8

Rats, Sprague-Dawley Rats, Wistar Dogs Mice, Inbred BALB C Rats, Inbred F344 Rats, Inbred Strains Rabbits Cattle

Diseases61

Brain Neoplasms Astrocytoma Breast Neoplasms Neoplasm Recurrence, Local Glioma Radiation Injuries Neoplasms Adenocarcinoma Neutropenia Disease Progression Lung Neoplasms Prostatic Neoplasms Leukopenia Neoplasm Metastasis Recurrence Thrombocytopenia Nausea Urinary Bladder Neoplasms Kidney Neoplasms Carcinoma Carcinoma, Transitional Cell Disease Models, Animal Meningioma Body Weight Sarcoma Neoplasm Invasiveness Ovarian Neoplasms Vomiting Carcinoma, Squamous Cell Lymphoma, Non-Hodgkin Hematologic Diseases Colorectal Neoplasms Meningeal Neoplasms Lymphatic Metastasis Carcinoma, Renal Cell Glioblastoma Stomatitis Carcinoma, Ductal, Breast Endometrial Neoplasms Carcinoma, Non-Small-Cell Lung Liver Neoplasms Acute Disease Graft vs Host Disease Head and Neck Neoplasms Supratentorial Neoplasms Radiation Pneumonitis Drug-Related Side Effects and Adverse Reactions Soft Tissue Neoplasms Carcinoma in Situ Bone Neoplasms Neoplasms, Radiation-Induced Precancerous Conditions Ependymoma Diarrhea Lymphoma, Follicular Pancreatic Neoplasms Pain Carcinoma, Endometrioid Mucositis Postoperative Complications Anemia

Chemicals and Drugs57

Antineoplastic Agents Fluorouracil Cisplatin Deoxycytidine Tumor Markers, Biological Antibodies, Monoclonal Camptothecin Taxoids Cyclophosphamide Doxorubicin Organoplatinum Compounds Antimetabolites, Antineoplastic Drug Combinations Carboplatin Ki-67 Antigen Leucovorin Antibodies, Monoclonal, Humanized Iodine Radioisotopes Recombinant Proteins Vinblastine Antineoplastic Agents, Alkylating Radioisotopes Placebos Etoposide Methotrexate Immunosuppressive Agents Radiopharmaceuticals Receptors, Estrogen Receptors, Progesterone Dacarbazine Pyridines Granulocyte Colony-Stimulating Factor Ifosfamide RNA, Messenger Antibiotics, Antineoplastic Vincristine Analgesics, Opioid Plant Extracts Piperazines Neoplasm Proteins Epirubicin Prednisone Topotecan Biological Markers Pyrazines Receptor, erbB-2 Piperidines Carcinogens Quinazolines Tegafur Delayed-Action Preparations Tumor Suppressor Protein p53 Indoles Pyrimidines Anti-Bacterial Agents DNA, Neoplasm Prostate-Specific Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment96

Treatment Outcome Radiation Dosage Administration, Oral Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Infusions, Intravenous Radiotherapy Dosage Dose Fractionation Radiometry Drug Administration Schedule Neoplasm Staging Retrospective Studies Prognosis Neoplasm Grading Dose-Response Relationship, Radiation Survival Analysis Follow-Up Studies Double-Blind Method Disease-Free Survival Area Under Curve Survival Rate Combined Modality Therapy Injections, Intravenous Prospective Studies Immunohistochemistry Radiotherapy Planning, Computer-Assisted Severity of Illness Index Radiotherapy, Intensity-Modulated Drug Therapy, Combination Kaplan-Meier Estimate Drug Evaluation Risk Factors Injections, Subcutaneous Metabolic Clearance Rate Body Burden Maximum Tolerated Dose Thermoluminescent Dosimetry Reproducibility of Results Feasibility Studies Cohort Studies Analysis of Variance Predictive Value of Tests Tomography, X-Ray Computed Radiotherapy Sensitivity and Specificity Multivariate Analysis Disease Models, Animal Metered Dose Inhalers Body Weight Random Allocation Radiation Monitoring Biopsy Salvage Therapy Radiosurgery Magnetic Resonance Imaging Remission Induction Injections, Intramuscular Risk Assessment Chemotherapy, Adjuvant Phantoms, Imaging Injections, Intraperitoneal Placebos Administration, Inhalation Blood Pressure Transplantation, Homologous Clinical Trials as Topic Proportional Hazards Models Statistics, Nonparametric Immunoenzyme Techniques Chromatography, High Pressure Liquid Treatment Failure Mitotic Index Radiotherapy, Adjuvant Incidence Infusions, Parenteral Models, Biological Regression Analysis Case-Control Studies Heart Rate Whole-Body Counting Monte Carlo Method Single-Blind Method Chemoradiotherapy Hematopoietic Stem Cell Transplantation Tumor Burden Chi-Square Distribution Pain Measurement Observer Variation Bone Marrow Transplantation Delayed-Action Preparations Neoadjuvant Therapy Logistic Models Randomized Controlled Trials as Topic Immunization Schedule Biopsy, Needle Radiotherapy, High-Energy

Psychiatry and Psychology3

Achievement Pain Motor Activity

Phenomena and Processes27

Radiation Dosage Time Factors Lethal Dose 50 Dose-Response Relationship, Radiation Area Under Curve Half-Life Metabolic Clearance Rate Drug Interactions Maximum Tolerated Dose Biological Availability Sensitivity and Specificity Body Weight Blood Pressure Pregnancy Dose-Response Relationship, Drug Dose-Response Relationship, Immunologic Drug Synergism Drug Tolerance Gene Expression Regulation, Neoplastic Heart Rate Gamma Rays Drug Resistance, Neoplasm Chi-Square Distribution Pain Motor Activity Algorithms Hemodynamics

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

United States Department of Agriculture Students Educational Measurement

Technology, Industry, Agriculture1

Information Science6

Survival Rate Radiotherapy Planning, Computer-Assisted Radiotherapy, Intensity-Modulated Incidence Monte Carlo Method Algorithms

Named Groups2

Students Infant, Newborn

Health Care45

Treatment Outcome Radiation Dosage Retrospective Studies Dose-Response Relationship, Radiation Survival Analysis Follow-Up Studies Double-Blind Method Disease-Free Survival Area Under Curve Survival Rate Prospective Studies Radiation Injuries Severity of Illness Index Kaplan-Meier Estimate Risk Factors Body Burden Thermoluminescent Dosimetry Reproducibility of Results Feasibility Studies Cohort Studies Analysis of Variance Predictive Value of Tests Relative Biological Effectiveness Age Factors Sensitivity and Specificity United States Department of Agriculture Multivariate Analysis Random Allocation Radiation Monitoring Risk Assessment Safety Clinical Trials as Topic Proportional Hazards Models Statistics, Nonparametric Treatment Failure Incidence Regression Analysis Case-Control Studies Monte Carlo Method Sex Factors Single-Blind Method Chi-Square Distribution Observer Variation Logistic Models Randomized Controlled Trials as Topic

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Treatment Outcome Radiation Dosage Administration, Oral Time Factors Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Infusions, Intravenous Radiotherapy Dosage Dose Fractionation Radiometry Drug Administration Schedule Neoplasm Staging Retrospective Studies Prognosis Neoplasm Grading Dose-Response Relationship, Radiation Survival Analysis Brain Neoplasms Antineoplastic Agents Follow-Up Studies Double-Blind Method Disease-Free Survival Area Under Curve Survival Rate Astrocytoma Breast Neoplasms Combined Modality Therapy Injections, Intravenous Prospective Studies Neoplasm Recurrence, Local Immunohistochemistry Fluorouracil Radiotherapy Planning, Computer-Assisted Glioma Radiation Injuries Neoplasms Adenocarcinoma Neutropenia Cisplatin Disease Progression Deoxycytidine Half-Life Tumor Markers, Biological Lung Neoplasms Severity of Illness Index Radiotherapy, Intensity-Modulated Drug Therapy, Combination Kaplan-Meier Estimate Antibodies, Monoclonal Prostatic Neoplasms Drug Evaluation Leukopenia Neoplasm Metastasis Recurrence Risk Factors Camptothecin Taxoids Injections, Subcutaneous Cyclophosphamide Metabolic Clearance Rate Doxorubicin Drug Interactions Rats, Sprague-Dawley Organoplatinum Compounds Thrombocytopenia Body Burden Maximum Tolerated Dose Antimetabolites, Antineoplastic Thermoluminescent Dosimetry Nausea Reproducibility of Results Feasibility Studies Cohort Studies Biological Availability Analysis of Variance Urinary Bladder Neoplasms Drug Combinations Carboplatin Predictive Value of Tests Ki-67 Antigen Tomography, X-Ray Computed Relative Biological Effectiveness Liver Radiotherapy Leucovorin Age Factors Sensitivity and Specificity United States Department of Agriculture Kidney Neoplasms Multivariate Analysis Carcinoma Carcinoma, Transitional Cell Disease Models, Animal Meningioma Metered Dose Inhalers Body Weight Random Allocation Radiation Monitoring Biopsy Salvage Therapy

No FAQ available that match "doses of pharmaceutical grade acetyldigitoxin"